A Phase 1 Study of HMPL-306 in Locally Advanced Solid Tumors with IDH mutations

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516370-30-00

Acronym

2020-306-GLOB2

Enrollment

Registered

2024-09-04

Start date

2021-02-09

Completion date

2025-02-27

Last updated

2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

- Locally advanced or metastatic solid tumors - Cholangiocarcinoma - Skeletal chondrosarcoma - Low-grade glioma - Any other solid tumor harboring an IDH mutation

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Spain

Outcome results